Literature DB >> 10092722

Number needed to treat (NNT).

W H Cordell1.   

Abstract

Because decisions regarding therapy are so common in clinical practice, the application of number needed to treat (NNT) is one of the most important evidence-based medicine skills to be acquired. NNT provides a clinically useful "yardstick" of the effort required to have a beneficial outcome or prevent a bad outcome with a therapy. A brief overview of the concept, derivation, and application of NNT is presented.

Mesh:

Year:  1999        PMID: 10092722     DOI: 10.1016/s0196-0644(99)70308-2

Source DB:  PubMed          Journal:  Ann Emerg Med        ISSN: 0196-0644            Impact factor:   5.721


  6 in total

1.  [Clinical relevance of tooth brushing in relation to dental caries].

Authors:  Salvador Pita-Fernández; Antonio Pombo-Sánchez; Juan Suárez-Quintanilla; Silvia Novio-Mallón; Berta Rivas-Mundiña; Sonia Pértega-Díaz
Journal:  Aten Primaria       Date:  2010-02-01       Impact factor: 1.137

2.  Comparison of ramosetron, dexamethasone, and a combination of ramosetron and dexamethasone for the prevention of postoperative nausea and vomiting in Korean women undergoing thyroidectomy: A double-blind, randomized, controlled study.

Authors:  Younghoon Jeon; Hyunjee Kim; Kyung-Hwa Kwak
Journal:  Curr Ther Res Clin Exp       Date:  2010-02

3.  An economic evaluation of voriconazole versus amphotericin B for the treatment of invasive aspergillosis in Canada.

Authors:  Coleman Rotstein; Michel Laverdière; Anne Marciniak; Farzad Ali
Journal:  Can J Infect Dis Med Microbiol       Date:  2004-09       Impact factor: 2.471

4.  A time-series analysis of air pollution and preterm birth in Pennsylvania, 1997-2001.

Authors:  Sharon K Sagiv; Pauline Mendola; Dana Loomis; Amy H Herring; Lucas M Neas; David A Savitz; Charles Poole
Journal:  Environ Health Perspect       Date:  2005-05       Impact factor: 9.031

5.  How should we describe the benefits of palliative radiotherapy?

Authors:  R Samant; T Tucker
Journal:  Curr Oncol       Date:  2006-12       Impact factor: 3.677

6.  Treatment of patients with type 2 diabetes with exenatide once weekly versus oral glucose-lowering medications or insulin glargine: achievement of glycemic and cardiovascular goals.

Authors:  Alison R Meloni; Mary Beth DeYoung; Jenny Han; Jennie H Best; Michael Grimm
Journal:  Cardiovasc Diabetol       Date:  2013-03-23       Impact factor: 9.951

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.